Work

Apixaban versus warfarin in patients with atrial fibrillation according to prior warfarin use: Results from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial

Year: 2013

Type: article

Source: American Heart Journal

DOI: 10.1016/j.ahj.2013.05.016

Authors: David A. Garcia, Lars Wallentin, Renato D. Lopes, Laine Thomas, John H. Alexander, Elaine M. Hylek, Jack Ansell, Michael Hanna, Fernando Lanas, Greg Flaker, Patrick Commerford, Denis Xavier, Dragos Vinereanu, Hongqiu Yang, Christopher B. Granger

Institutions: University of Washington, Uppsala University, Duke Medical Center, Duke Clinical Research Institute, Boston University, Boston Medical Center, Lenox Hill Hospital, Bristol-Myers Squibb (United States), Universidad de La Frontera, University of Missouri Health System, University of Cape Town, St. John's Research Institute

Language: English

Topic: Atrial Fibrillation Management and Outcomes

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Bristol-Myers Squibb, Pfizer

OpenAlex ID: W2099422917

FWCI: 5.668

Cites: 14

Cited by: 53

Related to: 10